Donald P. Tashkin
0000-0002-5607-4872
Publication & Citation Trends
Publications
0 total
Re-envisioning clinical trial design in systemic sclerosis
Cited by 2
Semantic Scholar
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts
Cited by 4
Semantic Scholar
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis–Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator‐Initiated, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
Cited by 1
Semantic Scholar
A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts
Cited by 0
Semantic Scholar
POS0939 CLINICAL OUTCOME MEASURES THAT ARE READY FOR PHASE III TRIALS IN SYSTEMIC SCLEROSIS
Cited by 0
Semantic Scholar
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease
Cited by 2
Semantic Scholar
Treatment Response Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease
Cited by 5
Semantic Scholar
Biological correlates of radiological features of systemic sclerosis interstitial lung disease OA
Cited by 3
Semantic Scholar
Research Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
(356)
Asthma and respiratory diseases
(225)
Respiratory Support and Mechanisms
(136)
Inhalation and Respiratory Drug Delivery
(131)
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
(97)
Affiliations
Rutgers, The State University of New Jersey
Sprint (United States)
Boston University
University of North Carolina at Chapel Hill
University of Southern California